SCHEMBL4901229

SCHEMBL4901229

Clc1cnc(-c2cccc(Nc3ccccn3)n2)s1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 5/20 0.58
NPC1 O15118 6/20 0.45
RAB9A P51151 6/20 0.45
KMT2A Q03164 5/20 0.45
TP53 P04637 4/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
TDP1 Q9NUW8 3/20 0.45
LMNA P02545 2/20 0.45
KDM4E B2RXH2 1/20 0.45
ALOX15 P16050 1/20 0.45
TSHR P16473 1/20 0.45
ALOX12 P18054 1/20 0.45
HTT P42858 1/20 0.45
KLF5 Q13887 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
PIM1 P11309 1/20 0.44
MECP2 P51608 1/20 0.43
KCNN1 Q92952 1/20 0.43
KCNN2 Q9H2S1 1/20 0.43
MBD2 Q9UBB5 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4900758 0.83 KDR (0.58) KDRNPC1RAB9AKMT2ATP53
SCHEMBL4900827 0.80 KDR (0.43) KDRNPC1RAB9AKMT2ATP53
SCHEMBL4896924 0.80 KMT2A (0.42) KDRNPC1RAB9AKMT2ATP53
SCHEMBL20919346 0.78 KMT2A (0.57) KDRNPC1RAB9AKMT2ATP53
SCHEMBL4892130 0.78 CCNA2 (0.44) TYK2KARS1
SCHEMBL4897029 0.78 KDR (0.49) KDRNPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL4893114 0.77 CDK2 (0.45) KDRPIM1TYK2ABL1MAPK1
Hydrochloric Acid SCHEMBL4902686 0.77 KDR (0.48) KDRNPC1RAB9AKMT2ASMN1; SMN2
Hydrochloric Acid SCHEMBL27682318 0.76 CDK2 (0.45) KDRPIM1TYK2ABL1MAPK1
SCHEMBL4899437 0.75 RAB9A (0.49) NPC1RAB9AKMT2ATP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080108600-A1 Polycyclic Pyridines as Potassium Ion Channel Modulators ICAGEN, INC. (US) 2008-05-08 US disclosed
CN-1980923-A Polycyclic pyridines as potassium ion channel modulators ICAGEN INC (US) 2007-06-13 CN disclosed
EP-1737852-A2 POLYCYCLIC PYRIDINES AS POTASSIUM ION CHANNEL MODULATORS Icagen, Inc. (US) 2007-01-03 EP disclosed
WO-2005100349-A2 POLYCYCLIC PYRIDINES AS POTASSIUM ION CHANNEL MODULATORS ICAGEN, INC. (US) 2005-10-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108600-A1 Polycyclic Pyridines as Potassium Ion Channel Modulators KCNJ2, KCNH2, KCNQ1 KDR 3367/4885NPC1 1509/4885RAB9A 3132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.